2019 American Transplant Congress

Saturday, June 1, 2019

5:30pm-7:30pm

Donor Renal Macrophages in Post-Transplant Ischemia/Reperfusion Injury (IRI): Role of IL-1R8 in Modulating Fate, Phenotype and Function

S. Aiello, P. Rodriguez, N. Azzollini, F. Casiraghi, M. Noris, G. Remuzzi, A. Benigni

Poster Session A: Ischemia Reperfusion & Organ Rehabilition  •  Hall C & D

5:30pm-7:30pm

Donor-derived Cell-free Dna In Donor Specific Antibody Positive Kidney Transplant Recipients

D. Cheng¹, X. Li², T. Jiang², H. Liu², Y. Zhou³, H. Shi³

Poster Session A: Acute Rejection  •  Hall C & D

5:30pm-7:30pm

Donor-Derived Cell-Free DNA is Associated Specifically with Antibody Mediated Injury in Patients with Renal Allograft Dysfunction

B. Obrisca¹, C. Blosser², I. De Castro², C. Johnson², B. Sorohan¹, L. Sibulesky², R. Bakthavatsalam², G. Ismail¹, N. Leca²

Poster Session A: Biomarkers, Immune Monitoring and Outcomes  •  Hall C & D

5:30pm-7:30pm

Donor-Recipient Matching in Kidney Transplant: The Whole is Greater Than the Sum of the Parts

A. Vinson, K. Tennankore, B. Kiberd

Poster Session A: Kidney Deceased Donor Allocation  •  Hall C & D

5:30pm-7:30pm

Dosing and Exposure over 2 Years with LCP-Tacrolimus (LCPT) vs. Immediate-Release Tacrolimus (IR-Tac) in De Novo Kidney Transplantation

K. Budde¹, S. Bunnapradist², S. Patel³, D. Stevens³, U. Meier-Kriesche³, B. Suwelack⁴

Poster Session A: Kidney Immunosuppression: Novel Regimens and Drug Minimization  •  Hall C & D

5:30pm-7:30pm

Dosing Requirements Of Astagraf Xl In African American Kidney Transplant Recipients Converted From Twice-daily Tacrolimus (aaaktrs)

J. N. Fleming, M. A. Posadas-Salas, D. J. Taber

Poster Session A: Kidney Immunosuppression: Novel Regimens and Drug Minimization  •  Hall C & D

5:30pm-7:30pm

DR53, You Can’t See Me: A Deceased Donor Tale of Ambiguous Typing

S. Dionne¹, S. Shetty¹, L. Santiago¹, K. Klama²

Poster Session A: Kidney Deceased Donor Allocation  •  Hall C & D

5:30pm-7:30pm

Dual Treatment of CD40 Silencing or Mesenchymal Stem Cells Infusion with Sub-Therapeutic Doses of Cyclosporine Effectively Prevents Acute Rejection in an Allogenic Model of Renal Transplantation

J. Guiteras¹, L. De Ramon¹, N. Bolaños¹, M. Franquesa², M. Gomà³, J. Cruzado⁴, N. Lloberas¹, J. Grinyó⁴, J. Torras⁴

Poster Session A: Acute Rejection  •  Hall C & D

5:30pm-7:30pm

Dynamic Characterization of Cells in the Perfusate from Cold Ischemic Liver Grafts

R. J. de Vries, C. Pendexter, S. E. Cronin, B. Marques, J. F. Markmann, S. L. Stott, H. Yeh, M. Toner, K. Uygun, S. N. Tessier

Poster Session A: Biomarkers, Immune Monitoring and Outcomes  •  Hall C & D

5:30pm-7:30pm

Early Achievement of Sustained Virological Response in Liver Transplant Recipients with Hepatitis C Reduces Risks of End Stage Renal Disease

M. Yoshikawa¹, T. Fukumoto²

Poster Session A: Liver - Kidney Issues in Liver Transplantation  •  Hall C & D